HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
Clinical trial NCT07629778 · RECRUITING
Trial details
- NCT number
- NCT07629778
- Sponsor
- Hangzhou Highlightll Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-26
- Primary completion
- 2027-06-30
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.